Global X Management Company’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Global X Management Company's BMY Position: Q2 2018 in Review
Global X Management Company increased its Bristol-Myers Squibb (BMY) stake by 20% in Q2 2018, buying an estimated $75.7K and bringing the position to 8,451 shares worth $468K. The position accounts for 0.01% of the portfolio, ranked #706.
Global X Management Company first reported a position in BMY in Q2 2013 and has held it in 21 quarters since. The position peaked at $1.65M in Q4 2013. 1,691 funds tracked by Wall St. Rank hold BMY as of Q2 2018.
- Global X Management Company held 8,451 shares of Bristol-Myers Squibb worth $468K as of Q2 2018.
- Global X Management Company bought 1,402 Bristol-Myers Squibb shares in Q2 2018, an estimated $75.7K.
- Bristol-Myers Squibb made up 0.01% of Global X Management Company's portfolio in Q2 2018, its #706 holding.
- Global X Management Company first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 21 quarters since.
- Global X Management Company's Bristol-Myers Squibb position peaked at $1.65M in Q4 2013.
- 1,691 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2018.
Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.